Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chabannon

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
Cancer Gene Therapy|August 7, 1998
A defective retroviral vector encoding human interferon-alpha2 can transduce human leukemic cell linesE Austruy, C Bagnis, N Carbuccia, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Ex vivo expansion of human peripheral blood progenitorsC Chabannon, D Herrera-Rodriguez, F Bardin, et al.
Hematology and Cell Therapy|May 27, 1999
The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell technologyC Chabannon, G Novakovitch, J L Blache, et al.
Blood|October 25, 2001
Forced expression of the Ikaros 6 isoform in human placental blood CD34(+) cells impairs their ability to differentiate toward the B-lymphoid lineageC Tonnelle, F Bardin, C Maroc, et al.
Blood|March 15, 1995
Granulocyte colony-stimulating factor-mobilized allogeneic peripheral blood stem cells for rescue graft failure after allogeneic bone marrow transplantation in two patients with acute myeloblastic leukemia in first complete remissionL Molina, C Chabannon, F Viret, et al.
Bone Marrow Transplantation|December 12, 2002
Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II studyF Viret, F Bertucci, D Genre, et al.
Bone Marrow Transplantation|March 19, 2023
Activity of ex vivo graft and DLI Engineering within the last decade increases, a survey from the EBMT Cellular Therapy & Immunobiology Working PartyM A de Witte, J E Mooyaart, J D Hoogenboom, et al.
Cytotherapy|May 7, 2010
T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselection of CD34(+) cellsS Olivero, G Novakovitch, P Ladaique, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): final analysis of survival in two consecutive ISC trialsR Bouabdallah, A M Stoppa, D Coso, et al.
Journal of Hematotherapy|June 1, 1995
Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factorC Chabannon, A G Le Coroller, C Faucher, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Cancer Gene Therapy|August 7, 1998
A defective retroviral vector encoding human interferon-alpha2 can transduce human leukemic cell linesE Austruy, C Bagnis, N Carbuccia, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Ex vivo expansion of human peripheral blood progenitorsC Chabannon, D Herrera-Rodriguez, F Bardin, et al.
Hematology and Cell Therapy|May 27, 1999
The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell technologyC Chabannon, G Novakovitch, J L Blache, et al.
Blood|October 25, 2001
Forced expression of the Ikaros 6 isoform in human placental blood CD34(+) cells impairs their ability to differentiate toward the B-lymphoid lineageC Tonnelle, F Bardin, C Maroc, et al.
Blood|March 15, 1995
Granulocyte colony-stimulating factor-mobilized allogeneic peripheral blood stem cells for rescue graft failure after allogeneic bone marrow transplantation in two patients with acute myeloblastic leukemia in first complete remissionL Molina, C Chabannon, F Viret, et al.
Bone Marrow Transplantation|December 12, 2002
Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II studyF Viret, F Bertucci, D Genre, et al.
Bone Marrow Transplantation|March 19, 2023
Activity of ex vivo graft and DLI Engineering within the last decade increases, a survey from the EBMT Cellular Therapy & Immunobiology Working PartyM A de Witte, J E Mooyaart, J D Hoogenboom, et al.
Cytotherapy|May 7, 2010
T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselection of CD34(+) cellsS Olivero, G Novakovitch, P Ladaique, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): final analysis of survival in two consecutive ISC trialsR Bouabdallah, A M Stoppa, D Coso, et al.
Journal of Hematotherapy|June 1, 1995
Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factorC Chabannon, A G Le Coroller, C Faucher, et al.
Pageof 14